Jonathan Weiss / Shutterstock
Eli Lillys The Phase III SURPASS 2 clinical trial shows treatment with tirzepatide, a once-weekly dual glucose-dependent insulinotropic polypeptide and glucagon-like...
More than 400 million people worldwide have diabetes, most of them type 2 diabetes.
Before developing type 2 diabetes itself, people are often diagnosed with...